(NASDAQ: HSIC) Henry Schein's forecast annual revenue growth rate of 6.18% is not forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 7.83%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.92%.
Henry Schein's revenue in 2024 is $12,339,000,000.On average, 9 Wall Street analysts forecast HSIC's revenue for 2024 to be $1,723,164,541,466, with the lowest HSIC revenue forecast at $1,711,259,257,635, and the highest HSIC revenue forecast at $1,739,838,929,541. On average, 9 Wall Street analysts forecast HSIC's revenue for 2025 to be $1,802,641,987,519, with the lowest HSIC revenue forecast at $1,770,977,150,312, and the highest HSIC revenue forecast at $1,837,156,310,540.
In 2026, HSIC is forecast to generate $1,904,021,434,296 in revenue, with the lowest revenue forecast at $1,873,499,012,930 and the highest revenue forecast at $1,949,508,860,661.